Ningbo Chaosheng Import and Export Co., Ltd. – Trademark Portfolio

Entity Type: 99

Ningbo Chaosheng Import and Export Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include YLCSH. The owner is based in Ningbo City, Zhejiang.

No. 86, Yongmao West Road

Luotuo Street, Zhenhai District

Ningbo City, Zhejiang 315201 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YLCSH
YLCSH
Registered 2020

Trademark Classifications

Ningbo Chaosheng Import and Export Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Ningbo Chaosheng Import and Export Co., Ltd. have?

Ningbo Chaosheng Import and Export Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Ningbo Chaosheng Import and Export Co., Ltd. file in?

Ningbo Chaosheng Import and Export Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Ningbo Chaosheng Import and Export Co., Ltd.'s most well-known trademarks?

Ningbo Chaosheng Import and Export Co., Ltd.'s registered trademark portfolio includes well-known marks such as YLCSH. These are among 1 currently registered trademark in the portfolio.

What is Ningbo Chaosheng Import and Export Co., Ltd.'s trademark registration success rate?

Ningbo Chaosheng Import and Export Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.